Washington, DC: The US Food and Drug Administration (FDA) has issued a warning that the liver disease medicine Ocaliva (obeticholic acid) is being incorrectly dosed in some patients with moderate to severe decreases in liver function, resulting in an increased risk of serious liver injury and death. [Original Article]
